Organisation paid for research Program year 2023 Source: CMS Open Payments

Advanced Pharmaceutical Development Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$58,262

10 payments

Through program year 2023, Advanced Pharmaceutical Development Clinical Research is reported as receiving $58,262 in research payments, across 10 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$19,703	5
2022	Research	$38,559	5

Breakdown

Who paid Research payments · program years 2022–2023

Biohaven Pharmaceutical Holding Company Ltd. $52,145 8 payments
Pfizer Inc. $6,117 2 payments

Studies the money was for Research payments · program years 2022–2023

A Phase 4 Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens $38,559 5 payments
A Phase 4 Randomized Doubleblind Placebocontrolled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens $19,703 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.